Keywords: مسیر جایگزین مکمل; Alternative pathway of complement; Paroxysmal nocturnal hemoglobinuria; Atypical hemolytic uremic syndrome; HELLP syndrome; Cold agglutinin disease; Complementopathy;
مقالات ISI مسیر جایگزین مکمل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مسیر جایگزین مکمل; Paroxysmal nocturnal hemoglobinuria; Hemolytic anemia; Alternative pathway of complement; Humanized anti-C5 monoclonal antibody; Eculizumab; C3 blockade; C1 inhibition; Bone marrow failure;
Keywords: مسیر جایگزین مکمل; alternative pathway of complement; C3 glomerulonephritis; membranoproliferative glomerulonephritis; persistent glomerulonephritis; postinfectious glomerulonephritis;
C3 glomerulopathy associated with monoclonal Ig is a distinct subtype
Keywords: مسیر جایگزین مکمل; alternative pathway of complement; C3 glomerulonephritis; C3 glomerulopathy; dense deposit disease; monoclonal Ig;
Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia
Keywords: مسیر جایگزین مکمل; APC; alternative pathway of complement; Cp40; second generation Compstatin analogue; DV; digestive vacuole; MESF; molecules of equivalent soluble fluorochrome; NHS; normal human serum; PNH; paroxysmal nocturnal hemoglobinuria; RBC; red blood cell; Malaria
Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro
Keywords: مسیر جایگزین مکمل; AP; alternative pathway of complement; CARPA; complement activation-related pseudoallergy; CCP; complement control protein domain; CFHR1; factor H-related protein 1; CrEL; Cremophor EL; FH; factor H; FH1-4; CCPs 1-4 of FH; FH15-20; CCPs 15-20 of FH; mAb;
Secondary Focal and Segmental Glomerulosclerosis Associated With Single-Nucleotide Polymorphisms in the Genes Encoding Complement Factor H and C3
Keywords: مسیر جایگزین مکمل; Focal and segmental glomerulosclerosis (FSGS); chronic thrombotic microangiopathy; alternative pathway of complement; factor H; C3;
Association of a Novel Complement Factor H Mutation With Severe Crescentic and Necrotizing Glomerulonephritis
Keywords: مسیر جایگزین مکمل; Crescentic glomerulonephritis; alternative pathway of complement; factor H mutation; C3 glomerulonephritis;
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
Keywords: مسیر جایگزین مکمل; alternative pathway of complement; C3 glomerulonephritis; C3 glomerulopathy; C3GN; MPGN; proteomics
Membranoproliferative Glomerulonephritis: Pathogenetic Heterogeneity and Proposal for a New Classification
Keywords: مسیر جایگزین مکمل; Membranoproliferative glomerulonephritis; MPGN; MGUS; monoclonal gammopathy; alternative pathway of complement; C3 glomerulopathy; C3-GN
Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks
Keywords: مسیر جایگزین مکمل; SGE; salivary gland extract; CVF; cobra venom factor; GVB; gelatin-veronal buffered saline; EGTA; ethyleneglycoltetra-acetic acid; REAP; rabbit erythrocyte alternative pathway activation assay; Complement; Ticks; Ixodes ricinus; Alternative pathway of com
IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase
Keywords: مسیر جایگزین مکمل; AP; alternative pathway of complement; C3NeF; C3 nephritic factor; GPBS, PBS; containing 0.1% gelatin; GVBS, VBS; containing 0.1% gelatin; IK; immunoconglutinins; IVIG; pooled human IgG for intravenous application; MPGN; membranoproliferative glomerulonep